Nov 11, 2009 8:00am EST OPKO Health Completes Acquisition of NK-1 Compounds from Schering Corporation
Jun 15, 2009 11:07am EDT OPKO Invests in Biotechnology Company with Novel Approach to Developing New Drugs
Jun 12, 2009 8:30am EDT Jamie Freedman, M.D., Ph.D. Joins OPKO Health as Executive Vice President of R&D and Business Development